3D Printed Drugs Market size was valued at US$ 334.30 Mn in 2023 and is expected to reach US$ 575.54 Mn by 2030 to exhibit a CAGR of 8.07 % during a forecast period. 3D printed technology for medicines is an innovative and cost-saving technology to deliver medications with easiness. 3D printed drugs are used to develop medications with controlled release of drugs, and those containing fixed-dose combinations. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. The bonding of powdered materials between liquid materials to generate 3D printed drugs, makes the formulations very permeable to fluids. 3D printed drugs dissolve as soon as when they come into contact with a small quantity of liquid. This helps controlling medications to children, physically impaired patients as well as those patients who are suffering from seizures.To know about the Research Methodology :- Request Free Sample Report The key factors enhancing the growth of market are the technological innovations in 3D printing procedures, the instant solubility of the drug in the mouth, and an increasing number of epilepsy patients. Epilepsy is a disorder in which nerve cell activity in the brain is disturbed, causing seizures like symptoms of a brain problem. However, blueprint hacking and mislabelling of blueprint is expected to hamper the growth of the market. Moreover, dicey regulatory scenario is another major restraint. Growing adoption of new generation 3D printing technology, rising technological advancement and spending on research and development by the top pharmaceutical companies such as GlaxoSmithKline are boosting the growth of 3D printed drug market. However, dearth of government regulations related to 3D printed drugs and adverse effects of 3D printed drugs are expected to hinder the growth of the market. Aprecia Company successfully developed the world’s first 3D printed drug known as Spritam. Aprecia has gained approval from the food & drug administration and is on sale in the U.S market at present. Asia Pacific is leading share of 34.1% in the 3D printed drugs market and expected to witness lucrative growth and registering a CAGR of 18.2% during the forecast period. Rapid development of healthcare infrastructure and growing investment in research and development of healthcare sector are projected to boost the growth of 3D printed drugs market in Asia Pacific region. Asia Pacific countries such as China & India are expected to grow at the highest rate in the 3D printed drugs market in few years, due to massive investments in both R&D as well as the pharmaceutical industry. Europe region is also projected to witness satisfactory growth during the forecast period, owing to the growing health consciousness among people of Europe region. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global 3D printed drugs market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in global 3D printed drugs market.
3D Printed Drugs Market Scope: Inquire before buying
3D Printed Drugs Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 334.30 Mn. Forecast Period 2024 to 2030 CAGR: 8.07% Market Size in 2030: US $ 575.54 Mn. Segments Covered: by Scenario Low Growth Scenario Moderate Growth Scenario Rapid Growth Scenario by End User Hospitals Clinics Research Laboratories Other 3D Printed Drugs Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)3D Printed Drugs Market Key Players:
Aprecia Extend Biosciences Bioduro Affinity Therapeutics Osmotica Pharmaceuticals Acrux Thiomatrix Ico Therapeutics Inc. Formac Pharmaceuticals BiopharmX Pacira Pharmaceuticals Inc. 3D Printer Drug Machine FabRx Ltd. GlaxoSmithKline Plc. Hewlett Packard Caribe BV, LLC Merck KGaA Cycle Pharmaceuticals Tvasta AstraZeneca Biomedical Modeling Inc. General Electric Company Materialise NV Frequently Asked Questions: 1. Which region has the largest share in Global 3D Printed Drugs Market? Ans: Asia Pacific region held the highest share in 2023. 2. What is the growth rate of Global 3D Printed Drugs Market? Ans: The Global 3D Printed Drugs Market is growing at a CAGR of 8.07% during forecasting period 2024-2030. 3. What is scope of the Global 3D Printed Drugs Market report? Ans: Global 3D Printed Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global 3D Printed Drugs Market? Ans: The important key players in the Global 3D Printed Drugs Market are – Aprecia, Extend Biosciences, Bioduro, Affinity Therapeutics, Osmotica Pharmaceuticals, Acrux, Thiomatrix, Ico Therapeutics Inc., Formac Pharmaceuticals, BiopharmX, Pacira Pharmaceuticals Inc., 3D Printer Drug Machine, FabRx Ltd., GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, Merck KGaA, Cycle Pharmaceuticals, Tvasta, AstraZeneca, Biomedical Modeling Inc., General Electric Company, Materialise NV. 5. What is the study period of this Market? Ans: The Global 3D Printed Drugs Market is studied from 2023 to 2030.
1. 3D Printed Drugs Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. 3D Printed Drugs Market: Dynamics 2.1. 3D Printed Drugs Market Trends by Region 2.1.1. North America 3D Printed Drugs Market Trends 2.1.2. Europe 3D Printed Drugs Market Trends 2.1.3. Asia Pacific 3D Printed Drugs Market Trends 2.1.4. Middle East and Africa 3D Printed Drugs Market Trends 2.1.5. South America 3D Printed Drugs Market Trends 2.2. 3D Printed Drugs Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America 3D Printed Drugs Market Drivers 2.2.1.2. North America 3D Printed Drugs Market Restraints 2.2.1.3. North America 3D Printed Drugs Market Opportunities 2.2.1.4. North America 3D Printed Drugs Market Challenges 2.2.2. Europe 2.2.2.1. Europe 3D Printed Drugs Market Drivers 2.2.2.2. Europe 3D Printed Drugs Market Restraints 2.2.2.3. Europe 3D Printed Drugs Market Opportunities 2.2.2.4. Europe 3D Printed Drugs Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific 3D Printed Drugs Market Drivers 2.2.3.2. Asia Pacific 3D Printed Drugs Market Restraints 2.2.3.3. Asia Pacific 3D Printed Drugs Market Opportunities 2.2.3.4. Asia Pacific 3D Printed Drugs Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa 3D Printed Drugs Market Drivers 2.2.4.2. Middle East and Africa 3D Printed Drugs Market Restraints 2.2.4.3. Middle East and Africa 3D Printed Drugs Market Opportunities 2.2.4.4. Middle East and Africa 3D Printed Drugs Market Challenges 2.2.5. South America 2.2.5.1. South America 3D Printed Drugs Market Drivers 2.2.5.2. South America 3D Printed Drugs Market Restraints 2.2.5.3. South America 3D Printed Drugs Market Opportunities 2.2.5.4. South America 3D Printed Drugs Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For 3D Printed Drugs Industry 2.8. Analysis of Government Schemes and Initiatives For 3D Printed Drugs Industry 2.9. 3D Printed Drugs Market Trade Analysis 2.10. The Global Pandemic Impact on 3D Printed Drugs Market 3. 3D Printed Drugs Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 3.1.1. Low Growth Scenario 3.1.2. Moderate Growth Scenario 3.1.3. Rapid Growth Scenario 3.2. 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 3.2.1. Hospitals 3.2.2. Clinics 3.2.3. Research Laboratories 3.2.4. Other 3.3. 3D Printed Drugs Market Size and Forecast, by Region (2023-2030) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America 3D Printed Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 4.1.1. Low Growth Scenario 4.1.2. Moderate Growth Scenario 4.1.3. Rapid Growth Scenario 4.2. North America 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 4.2.1. Hospitals 4.2.2. Clinics 4.2.3. Research Laboratories 4.2.4. Other 4.3. North America 3D Printed Drugs Market Size and Forecast, by Country (2023-2030) 4.3.1. United States 4.3.1.1. United States 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 4.3.1.1.1. Low Growth Scenario 4.3.1.1.2. Moderate Growth Scenario 4.3.1.1.3. Rapid Growth Scenario 4.3.1.2. United States 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 4.3.1.2.1. Hospitals 4.3.1.2.2. Clinics 4.3.1.2.3. Research Laboratories 4.3.1.2.4. Other 4.3.2. Canada 4.3.2.1. Canada 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 4.3.2.1.1. Low Growth Scenario 4.3.2.1.2. Moderate Growth Scenario 4.3.2.1.3. Rapid Growth Scenario 4.3.2.2. Canada 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 4.3.2.2.1. Hospitals 4.3.2.2.2. Clinics 4.3.2.2.3. Research Laboratories 4.3.2.2.4. Other 4.3.3. Mexico 4.3.3.1. Mexico 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 4.3.3.1.1. Low Growth Scenario 4.3.3.1.2. Moderate Growth Scenario 4.3.3.1.3. Rapid Growth Scenario 4.3.3.2. Mexico 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 4.3.3.2.1. Hospitals 4.3.3.2.2. Clinics 4.3.3.2.3. Research Laboratories 4.3.3.2.4. Other 5. Europe 3D Printed Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.2. Europe 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 5.3. Europe 3D Printed Drugs Market Size and Forecast, by Country (2023-2030) 5.3.1. United Kingdom 5.3.1.1. United Kingdom 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.3.1.2. United Kingdom 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 5.3.2. France 5.3.2.1. France 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.3.2.2. France 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 5.3.3. Germany 5.3.3.1. Germany 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.3.3.2. Germany 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 5.3.4. Italy 5.3.4.1. Italy 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.3.4.2. Italy 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 5.3.5. Spain 5.3.5.1. Spain 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.3.5.2. Spain 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 5.3.6. Sweden 5.3.6.1. Sweden 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.3.6.2. Sweden 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 5.3.7. Austria 5.3.7.1. Austria 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.3.7.2. Austria 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 5.3.8.2. Rest of Europe 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6. Asia Pacific 3D Printed Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.2. Asia Pacific 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3. Asia Pacific 3D Printed Drugs Market Size and Forecast, by Country (2023-2030) 6.3.1. China 6.3.1.1. China 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.1.2. China 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.2. S Korea 6.3.2.1. S Korea 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.2.2. S Korea 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.3. Japan 6.3.3.1. Japan 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.3.2. Japan 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.4. India 6.3.4.1. India 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.4.2. India 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.5. Australia 6.3.5.1. Australia 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.5.2. Australia 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.6. Indonesia 6.3.6.1. Indonesia 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.6.2. Indonesia 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.7. Malaysia 6.3.7.1. Malaysia 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.7.2. Malaysia 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.8. Vietnam 6.3.8.1. Vietnam 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.8.2. Vietnam 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.9. Taiwan 6.3.9.1. Taiwan 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.9.2. Taiwan 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 6.3.10.2. Rest of Asia Pacific 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 7. Middle East and Africa 3D Printed Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 7.2. Middle East and Africa 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 7.3. Middle East and Africa 3D Printed Drugs Market Size and Forecast, by Country (2023-2030) 7.3.1. South Africa 7.3.1.1. South Africa 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 7.3.1.2. South Africa 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 7.3.2. GCC 7.3.2.1. GCC 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 7.3.2.2. GCC 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 7.3.3. Nigeria 7.3.3.1. Nigeria 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 7.3.3.2. Nigeria 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 7.3.4.2. Rest of ME&A 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 8. South America 3D Printed Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 8.2. South America 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 8.3. South America 3D Printed Drugs Market Size and Forecast, by Country (2023-2030) 8.3.1. Brazil 8.3.1.1. Brazil 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 8.3.1.2. Brazil 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 8.3.2. Argentina 8.3.2.1. Argentina 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 8.3.2.2. Argentina 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America 3D Printed Drugs Market Size and Forecast, by Scenario (2023-2030) 8.3.3.2. Rest Of South America 3D Printed Drugs Market Size and Forecast, by End User (2023-2030) 9. Global 3D Printed Drugs Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2023) 9.3.5. Company Locations 9.4. Leading 3D Printed Drugs Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Aprecia 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Extend Biosciences 10.3. Bioduro 10.4. Affinity Therapeutics 10.5. Osmotica Pharmaceuticals 10.6. Acrux 10.7. Thiomatrix 10.8. Ico Therapeutics Inc. 10.9. Formac Pharmaceuticals 10.10. BiopharmX 10.11. Pacira Pharmaceuticals Inc. 10.12. 3D Printer Drug Machine 10.13. FabRx Ltd. 10.14. GlaxoSmithKline Plc. 10.15. Hewlett Packard Caribe 10.16. BV, LLC 10.17. Merck KGaA 10.18. Cycle Pharmaceuticals 10.19. Tvasta 10.20. AstraZeneca 10.21. Biomedical Modeling Inc. 10.22. General Electric Company 10.23. Materialise NV 11. Key Findings 12. Industry Recommendations 13. 3D Printed Drugs Market: Research Methodology 14. Terms and Glossary